NOTES_NN
TO_PIN
THE_DT
CONSOLIDATED_JJ
FINANCIAL_NN
STATEMENTS_NOMZ
CONTINUED_VBD
2_CD
._.
Acquisitions_NOMZ
of_PIN
subsidiaries_NN
i_FPP1
Acquisition_NOMZ
of_PIN
Urology_NN
Solutions_NOMZ
Pty_NN
Limited_NN
On_PIN
16_CD
March_NN
2005_CD
,_,
the_DT
Group_NN
acquired_VBD
100_CD
%_NN
of_PIN
the_DT
equity_NOMZ
of_PIN
Urology_NN
Solutions_NOMZ
Pty_NN
Limited_NN
renamed_VBD
Gyrus_NN
Australasia_NN
Pty_NN
Limited_NN
,_,
the_DT
exclusive_JJ
distributor_NN
of_PIN
Gyruss_NN
surgical_JJ
products_NN
in_PIN
Australia_NN
and_PHC
New_NN
Zealand_NN
for_PIN
total_JJ
consideration_NOMZ
of_PIN
1,170,000_CD
satisfied_VBN
by_PIN
cash_NN
and_CC
deferred_VBN
consideration_NOMZ
._.
In_PIN
the_DT
nine_CD
months_NN
to_PIN
31_CD
December_NN
2005_CD
the_DT
subsidiary_NN
reduced_VBN
Group_NN
operating_GER
profit_NN
by_PIN
421,000_CD
._.
If_COND
the_DT
acquisition_NOMZ
had_VBD [PEAS]
occurred_VBN
on_PIN
1_CD
January_NN
2005_CD
,_,
the_DT
subsidiary_NN
would_PRMD
have_VB [PEAS]
reduced_VBN
Group_NN
operating_GER
profit_NN
by_PIN
460,000_CD
._.
Effect_NN
of_PIN
acquisition_NOMZ
The_DT
acquisition_NOMZ
had_VBD
the_DT
following_JJ
effect_NN
on_PIN
the_DT
Groups_NN
assets_NN
and_PHC
liabilities_NOMZ
._.
Acquirees_NN
book_NN
values_VPRT
Fair_NN
value_NN
adjustments_NOMZ
Acquisition_NOMZ
amounts_VPRT
Acquirees_NN
net_JJ
assets_NN
at_PIN
the_DT
acquisition_NOMZ
date_NN
000 000 000_CD
Property_NN
,_,
plant_NN
and_PHC
equipment_NOMZ
34_CD
34_CD
Intangible_JJ
assets_NN
387_CD
387_CD
Inventories_NN
318_CD
19_CD
337_CD
Trade_NN
and_CC
other_JJ
receivables_NN
125_CD
125_CD
Cash_NN
and_PHC
cash_NN
equivalents_NN
32_CD
32_CD
Trade_NN
and_CC
other_JJ
payables_NN
351 139 490_CD
Net_JJ
identifiable_JJ
assets_NN
and_PHC
liabilities_NOMZ
158 267 425_CD
Goodwill_NN
on_PIN
acquisition_NOMZ
745_CD
Total_JJ
consideration_NOMZ
1,170_CD
Satisfied_VBN
by_PIN
:_:
Cash_NN
797_CD
Deferred_JJ
consideration_NOMZ
373_CD
Total_JJ
consideration_NOMZ
1,170_CD
Cash_NN
consideration_NOMZ
797_CD
Less_RB
:_:
cash_NN
acquired_VBN [WZPAST]
on_PIN
acquisition_NOMZ
32_CD
Net_JJ
cash_NN
out_PIN
flow_NN
arising_VBG [WZPRES]
on_PIN
acquisition_NOMZ
765_CD
This_DEMO
acquisition_NOMZ
provides_VPRT
Gyrus_NN
with_PIN
the_DT
opportunity_NOMZ
to_TO
sell_VB
its_PIT
range_NN
of_PIN
ENT_NN
products_NN
through_PIN
this_DEMO
distribution_NOMZ
channel_NN
._.
Goodwill_NN
of_PIN
745,000_CD
has_VPRT [PEAS]
arisen_VBN
on_PIN
this_DEMO
transaction_NOMZ
as_CONJ
a_NULL
result_NULL
of_PIN
the_DT
potential_NN
for_PIN
generating_VBG
additional_JJ
sales_NN
._.
On_PIN
12_CD
May_POMD
2005_CD
,_,
Gyrus_NN
Australasia_NN
Pty_NN
Ltd_NN
took_VBD
over_RP
the_DT
distribution_NOMZ
of_PIN
ENT_NN
products_NN
in_PIN
Australia_NN
from_PIN
Global_NN
Scientific_NN
Pty_NN
Ltd_NN
and_CC
purchased_VBD
business_NOMZ
records_NN
and_PHC
inventory_NN
for_PIN
cash_NN
consideration_NOMZ
of_PIN
511,000_CD
._.
Acquirees_NN
book_NN
values_VPRT
Fair_NN
value_NN
adjustments_NOMZ
Acquisition_NOMZ
amounts_VPRT
000 000 000_CD
Intangible_JJ
assets_NN
161_CD
161_CD
Inventories_NN
346 103 243_CD
Net_JJ
identifiable_JJ
assets_NN
and_PHC
liabilities_NOMZ
346_CD
58_CD
404_CD
Goodwill_NN
on_PIN
acquisition_NOMZ
107_CD
Total_JJ
consideration_NOMZ
satisfied_VBN [WZPAST]
by_PIN
cash_NN
511_CD
The_DT
acquisition_NOMZ
of_PIN
business_NOMZ
records_NN
and_PHC
inventory_NN
from_PIN
Global_JJ
Scientific_NN
Pty_NN
Ltd_NN
provides_VPRT
Gyrus_NN
with_PIN
a_DT
further_JJ
opportunity_NOMZ
to_TO
sell_VB
its_PIT
range_NN
of_PIN
ENT_NN
products_NN
through_PIN
established_VBN [PRIV]
distribution_NOMZ
channels_NN
._.
Goodwill_NN
of_PIN
107,000_CD
has_VPRT [PEAS]
arisen_VBN
on_PIN
this_DEMO
transaction_NOMZ
as_CONJ
a_NULL
result_NULL
of_PIN
the_DT
potential_NN
for_PIN
generating_VBG
additional_JJ
sales_NN
._.
Gyrus_NN
Group_NN
PLC_NN
Annual_JJ
Report_NN
and_PHC
Accounts_NN
2005_CD
56_CD
ii_NN
Acquisition_NOMZ
of_PIN
American_NN
Cystoscope_NN
Makers_NN
Inc_NN
On_PIN
21_CD
July_NN
2005_CD
,_,
Gyrus_NN
Group_NN
PLC_NN
acquired_VBD
100_CD
%_NN
of_PIN
the_DT
share_NN
capital_NN
of_PIN
American_JJ
Cystoscope_NN
Makers_NN
Inc_NN
ACMI_NN
._.
ACMI_NN
designs_NN
,_,
manufactures_VPRT
,_,
markets_NN
and_PHC
services_NN
surgical_JJ
visualisation_NOMZ
and_PHC
treatment_NOMZ
systems_NN
used_VBN [WZPAST]
by_PIN
surgeons_NN
and_PHC
physicians_NN
primarily_RB
for_PIN
diagnosis_NN
and_CC
minimally_RB
invasive_JJ
surgery_NN
in_PIN
the_DT
field_NN
of_PIN
Urology_NN
and_PHC
Gynaecology_NN
._.
ACMI_NN
was_VBD [PASS]
acquired_VBN
for_PIN
a_DT
consideration_NOMZ
of_PIN
US$_$
332_CD
million_CD
plus_PIN
the_DT
assumption_NOMZ
of_PIN
debt_NN
and_CC
other_JJ
obligations_NOMZ
subsequently_TIME
repaid_VBN
by_PIN
the_DT
Company_NN
of_PIN
US$_$
168_CD
million_CD
less_JJ
the_DT
assumption_NOMZ
of_PIN
cash_NN
balances_NN
on_PIN
the_DT
date_NN
of_PIN
acquisition_NOMZ
._.
The_DT
consideration_NOMZ
was_VBD [BYPA]
satisfied_VBN
by_PIN
the_DT
issue_NN
of_PIN
61,560,025_CD
placing_VBG
shares_NN
at_PIN
250p_JJ
per_PIN
placing_VBG
share_NN
and_CC
new_JJ
banking_GER
facilities_NOMZ
._.
The_DT
entire_JJ
proceeds_NN
of_PIN
the_DT
allotment_NOMZ
of_PIN
the_DT
placing_VBG
shares_NN
which_WDT [WHSUB]
were_VBD [PASS]
issued_VBN
in_PIN
consideration_NOMZ
for_PIN
the_DT
outstanding_JJ
common_JJ
stock_NN
of_PIN
ACMI_NN
were_VBD [PASS]
paid_VBN
to_PIN
the_DT
Sellers_NN
._.
New_JJ
banking_GER
facilities_NOMZ
of_PIN
US$_$
280_CD
million_CD
include_VPRT
a_DT
five_CD
year_NN
fixed_VBN
term_NN
loan_NN
of_PIN
US$_$
250_CD
million_CD
and_CC
a_DT
US$_$
30_CD
million_CD
revolving_JJ
credit_NN
facility_NOMZ
secured_VBN [WZPAST]
by_PIN
a_DT
fixed_VBN
and_PHC
floating_VBG
charge_NN
over_IN
the_DT
assets_NN
of_PIN
the_DT
Group_NN
see_VB [PRIV]
note_NN
18_CD
._.
Acquirees_NN
book_NN
values_VPRT
Fair_NN
value_NN
adjustments_NOMZ
Acquisition_NOMZ
amounts_VPRT
000 000 000_CD
Property_NN
,_,
plant_NN
and_PHC
equipment_NOMZ
10,440_CD
1,991_CD
8,449_CD
Intangible_JJ
assets_NN
612_CD
108,812_CD
109,424_CD
Inventories_NN
15,938_CD
4,686_CD
20,624_CD
Trade_NN
and_CC
other_JJ
receivables_NN
16,442_CD
16,442_CD
Deferred_JJ
tax_NN
asset_NN
liability_NOMZ
216_CD
27,009_CD
26,793_CD
Cash_NN
and_PHC
cash_NN
equivalents_NN
2,642_CD
2,642_CD
Trade_NN
and_CC
other_JJ
payables_NN
30,243_CD
30,243_CD
Provisions_NN
2,245_CD
2,245_CD
Bank_NN
loan_NN
83,365_CD
83,365_CD
Net_JJ
identifiable_JJ
assets_NN
and_PHC
liabilities_NOMZ
69,563_CD
84,498_CD
14,935_CD
Goodwill_NN
on_PIN
acquisition_NOMZ
180,351_CD
Total_JJ
consideration_NOMZ
including_VBG [WZPRES]
costs_NN
195,286_CD
Purchase_NN
price_NN
of_PIN
$_$
332,460,951_CD
186,368_CD
Acquisition_NOMZ
costs_NN
taken_VBN [WZPAST]
to_PIN
cost_NN
of_PIN
investment_NOMZ
6,938_CD
Funds_NN
from_PIN
exercise_NN
of_PIN
option_NOMZ
1,980_CD
Total_JJ
consideration_NOMZ
195,286_CD
In_PIN
order_NN
to_TO
ensure_VB [SUAV] [PRIV]
that_THVC
116_CD
million_CD
of_PIN
placing_VBG
proceeds_NN
raised_VBN
would_PRMD
translate_VB
into_PIN
the_DT
minimum_NN
US$_$
amount_NN
required_VBN [SUAV] [WZPAST]
for_PIN
the_DT
completion_NOMZ
of_PIN
the_DT
acquisition_NOMZ
,_,
Gyrus_NN
Group_NN
PLC_NN
entered_VBD
into_PIN
an_DT
option_NOMZ
agreement_NOMZ
on_PIN
the_DT
announcement_NOMZ
date_NN
._.
The_DT
net_JJ
funds_NN
received_VBN [WZPAST]
from_PIN
the_DT
sale_NN
of_PIN
this_DEMO
option_NOMZ
,_,
approximately_RB
one_CD
month_NN
later_TIME
,_,
were_VBD [BEMA]
1,980,000_CD
._.
Satisfied_VBN [PASTP]
by_PIN
US$_$
000_CD
000_CD
Share_NN
placing_VBG [WZPRES]
153,901_CD
Cash_NN
32,467_CD
Purchase_NN
price_NN
332,461_CD
186,368_CD
Cash_NN
acquired_VBN
4,712_CD
2,642_CD
ACMI_NN
debt_NN
paid_VBN [WZPAST]
on_PIN
acquisition_NOMZ
167,763_CD
94,052_CD
Acquisition_NOMZ
costs_NN
10,721_CD
Net_JJ
cash_NN
outflow_NN
as_CONJ
a_NULL
result_NULL
of_PIN
the_DT
acquisition_NOMZ
495,512_CD
288,499_CD
Includes_VPRT
6,938,000_CD
of_PIN
acquisition_NOMZ
costs_NN
taken_VBN [WZPAST]
to_PIN
cost_NN
of_PIN
investment_NOMZ
and_CC
3,783,000_CD
of_PIN
acquisition_NOMZ
costs_NN
relating_VBG [WZPRES]
to_PIN
the_DT
share_NN
placing_VBG [WZPRES]
that_DEMP
were_VBD [PASS]
taken_VBN
to_PIN
the_DT
share_NN
premium_NN
account_NN
._.
Fair_NN
value_NN
adjustments_NOMZ
A_DT
valuation_NOMZ
was_VBD [PASS]
commissioned_VBN
to_TO
identify_VB
and_PHC
value_VB
intangible_JJ
assets_NN
._.
As_CONJ
a_NULL
result_NULL
of_PIN
the_DT
valuation_NOMZ
,_,
108,812,000_CD
of_PIN
intangible_JJ
assets_NN
were_VBD [PASS]
recognized_VBN [PRIV]
which_WDT
can_POMD
be_VB [PASS]
analyzed_VBN
as_IN
follows_VPRT
:_:
000_CD
Developed_VBN
product_NN
technology_NN
Urology_NN
12,557_CD
Developed_VBN
product_NN
technology_NN
Gynaecology_NN
4,148_CD
In_PIN
process_NN
R&D_NN
Urology_NN
9,362_CD
In_PIN
process_NN
R&D_NN
Gynaecology_NN
2,915_CD
Trademark_NN
tradename_NN
portfolio_NN
Urology_NN
28,141_CD
Trademark_NN
tradename_NN
portfolio_NN
Gynaecology_NN
5,662_CD
Customer_NN
relationships_NN
46,471_CD
Less_RB
:_:
amounts_NN
included_VBD
in_PIN
opening_VBG
balance_NN
sheet_NN
in_PIN
connection_NOMZ
with_PIN
the_DT
above_PLACE
444_CD
Total_JJ
108,812_CD
A_DT
valuation_NOMZ
study_NN
was_VBD [PASS]
commissioned_VBN
on_PIN
the_DT
land_NN
and_PHC
buildings_GER
owned_VBN [WZPAST]
by_PIN
ACMI_NN
._.
As_CONJ
a_NULL
result_NULL
of_PIN
the_DT
valuation_NOMZ
the_DT
value_NN
attributed_VBD
to_PIN
property_NN
,_,
plant_NN
and_PHC
equipment_NOMZ
was_VBD [BYPA]
reduced_VBN
by_PIN
1,991,000_CD
._.
Gyrus_NN
Group_NN
PLC_NN
Annual_JJ
Report_NN
and_PHC
Accounts_NN
2005_CD
57_CD
